Federal Update: Part B Stakeholders Testify before Congress
posted: May 1, 2016
Coalition of State Rheumatology Organizations (CSRO) testified before the Subcommittee on Health in opposition to the recent Medicare Part B Demo proposed by CMS.
The hearing, "The Obama Administration’s Medicare Drug Experiment: The Patient and Doctor Perspective," brought together stakeholders that would be adversely effected by the change in reimbursement for Part B drugs.
Bipartisan Step Therapy Letter Delivered to CMS
Congressman Leonard Lance (R-NJ) and Scott Peters (D-CA) have asked CMS to ensure step therapy protocols are open and transparent, do not create a barrier to access and do not take prescribing power out of the hands of physicians.